Taoka ChemicalTAOKA CHEMICAL COMPANY, LIMITED4113東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥6 is left as operating profit. Revenue changed +10.9% from the prior year, operating profit +8.4%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 6.4% | 1.00× | 6.4% | 1.95× | 12.4% |
| 2023 | 1.0% | 0.95× | 1.0% | 1.92× | 1.9% |
| 2024 | 2.9% | 0.94× | 2.7% | 1.82× | 4.9% |
| 2025 | 4.9% | 1.00× | 4.9% | 1.71× | 8.4% |
| 2026 | 4.6% | 1.08× | 5.0% | 1.64× | 8.2% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 32,374 | 30,167 | 28,544 | 29,930 | 33,192 |
| Cost of revenue | 26,053 | 26,166 | 23,966 | 24,439 | 27,422 |
| Gross profit | 6,321 | 4,000 | 4,578 | 5,491 | 5,769 |
| SG&A | 3,613 | 3,549 | 3,503 | 3,604 | 3,723 |
| Operating income | 2,708 | 451 | 1,075 | 1,887 | 2,046 |
| Pretax income | 2,769 | 478 | 1,128 | 1,963 | 2,060 |
| Income tax | 705 | 168 | 308 | 485 | 527 |
| Net income attributable to owners | 2,064 | 311 | 820 | 1,478 | 1,533 |
| Operating margin | 8.4% | 1.5% | 3.8% | 6.3% | 6.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥718.6M | ¥853M | ¥972M | ¥2.98B | ¥2.94B |
| Total assets | ¥32.4B | ¥31.1B | ¥29.7B | ¥30.4B | ¥30.9B |
| Net assets | ¥16.7B | ¥16.6B | ¥17.2B | ¥18.5B | ¥19.6B |
| Share capital | ¥1.57B | ¥1.57B | ¥1.57B | ¥1.57B | ¥1.57B |
| Property, plant and equipment | ¥13.2B | ¥13.5B | ¥13.3B | ¥13B | ¥12.3B |
| Intangible assets excluding goodwill | ¥60.4M | ¥54.5M | ¥49M | ¥40M | ¥79M |
| Investment securities | ¥93.2M | ¥68.6M | ¥87M | ¥88M | ¥122M |
| Current assets | ¥17.8B | ¥16.2B | ¥15.2B | ¥16.2B | ¥17.4B |
| Current liabilities | ¥12.2B | ¥9.63B | ¥8.28B | ¥8.28B | ¥8.63B |
| Short-term borrowings | ¥8.2M | ¥1.6B | ¥100M | — | — |
| Long-term borrowings | ¥480M | ¥2.11B | ¥1.49B | ¥870M | ¥250M |
| Total liabilities | ¥15.7B | ¥14.5B | ¥12.5B | ¥11.9B | ¥11.4B |
| Equity attributable to owners of parent | ¥16.6B | ¥16.4B | ¥17B | ¥18.2B | ¥19.2B |
| Retained earnings | ¥14.1B | ¥13.9B | ¥14.5B | ¥15.7B | ¥16.6B |
| Treasury stock | -¥39.5M | -¥39.5M | -¥40M | -¥40M | -¥40M |
EDINET (FSA Japan)
訂正有価証券報告書－第126期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第125期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第124期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第123期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第122期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第121期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 47 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.